Kyowa Pharmaceutical, Inc. (KPI)
NJ-based US. Subsidiary of Kyowa Hakko Kirin, one of Japan’s top pharmaceutical companies
| Engagement Overview:
Business-to-business visibility for licensing and acquisition opportunities; public education of istradefylline (KW-6002), under development for the potential treatment of Parkinson’s Disease; advocacy group and community relations; and issues management.
|
|